Pamela Pavco
2015 - RXi Pharmaceuticals
In 2015, Pamela Pavco earned a total compensation of $486.6K as Chief Development Officer at RXi Pharmaceuticals, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $104,025 |
|---|---|
| Option Awards | $18,480 |
| Salary | $363,808 |
| Other | $300 |
| Total | $486,613 |
Pavco received $363.8K in salary, accounting for 75% of the total pay in 2015.
Pavco also received $104K in non-equity incentive plan, $18.5K in option awards and $300 in other compensation.
Rankings
In 2015, Pamela Pavco's compensation ranked 10,944th out of 13,638 executives tracked by ExecPay. In other words, Pavco earned more than 19.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,944 out of 13,638 | 20th |
Division Manufacturing | 4,183 out of 5,190 | 19th |
Major group Chemicals And Allied Products | 1,538 out of 1,854 | 17th |
Industry group Drugs | 1,268 out of 1,528 | 17th |
Industry Pharmaceutical Preparations | 989 out of 1,182 | 16th |
Source: SEC filing on April 27, 2017.
Pavco's colleagues
We found one more compensation record of an executive who worked with Pamela Pavco at RXi Pharmaceuticals in 2015.
2015
Geert Cauwenbergh
RXi Pharmaceuticals